Browsing tag

Nathan Hellman

Drug Trials

Last week’s poll results:  who should provide funding for large, randomized controlled drug trials?  Most respondents (58%) chose the diplomatic answer and said that it should be a combination between government and pharmaceutical companies.  I was somewhat surprised…

946 0

AJKD Bundling Editorials

This month’s issue of AJKD includes an enlightening group of 6 editorials, each written from a unique perspective (e.g., the perspective of large dialysis corporations, the perspective of the ESRD Networks, the perspective of non-profit dialysis corporations, etc.),…

1507 0

The Business of Dialysis

An interesting figure in this month’s ASN Kidney News details the quarterly earnings for three major dialysis companies in the U.S.: DaVita, Dialysis Corporation of America (DCA), and Fresenius. Also included in the figure (not shown here) is…

1171 0

ASN’s New Logo

The American Society revealed its new logo with the new year: a male form with two glowing kidneys visible inside him, striding into the future (at least, that’s my interpretation as to what he is doing–I guess alternate…

2040 2

Interferon effects on the kidney

Interferons are cytokines which play a central role in the inflammatory response, and commercially prepared interferons have proven useful in the treatment of several diseases. For instance, interferon-alpha (often used in conjunction with ribavirin) is often used in…

3547 0
Load more